Diamond Investment Explains Three Consecutive Months of Negative Operating Revenue
Diamond Investment Co., Ltd. announced on April 9, 2026, that its operating revenue has been negative for three consecutive months. This is primarily due to valuation fluctuations in its biotech stock investments, prompting the company to warn investors of potential risks.
📋 Article Processing Timeline
- 📰 Published: April 9, 2026 at 09:00
- 🔍 Collected: April 10, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: April 19, 2026 at 02:54 (210h 54m after Collected)
1. Date of fact occurrence: 115/04/09
2. Company Name: Diamond Biotech Investment Co., Ltd.
3. Relationship with the Company (please enter 'This Company' or 'Subsidiary'): This Company
4. Proportion of mutual shareholding: Not applicable
5. Reason for occurrence:
Pursuant to the Taiwan Stock Exchange Corporation's letter Tai-Zheng Shang-Yi No. 1121802934, dated June 29, 2023, if the company's operating revenue is negative for three consecutive months, it shall issue a major information notice to alert investors.
6. Countermeasures:
The company's operating revenue is recognized based on the valuation gains/losses (both realized and unrealized) of its investment targets. As the operating revenue has been negative for three consecutive months, a major information notice is being issued to alert investors.
7. Other matters to be noted (if the subject of the event or resolution is a publicly issued company or above, this major information also meets the criteria of Article 7, Paragraph 9 of the Enforcement Rules of the Securities Transaction Act regarding material impact on shareholder rights or securities prices):
The company's main investment targets are in the biotechnology sector, where stock prices and fair values are significantly affected by R&D outcomes, leading to substantial fluctuations. Therefore, a decline in fair value during the current year may result in negative operating revenue for the company.
2. Company Name: Diamond Biotech Investment Co., Ltd.
3. Relationship with the Company (please enter 'This Company' or 'Subsidiary'): This Company
4. Proportion of mutual shareholding: Not applicable
5. Reason for occurrence:
Pursuant to the Taiwan Stock Exchange Corporation's letter Tai-Zheng Shang-Yi No. 1121802934, dated June 29, 2023, if the company's operating revenue is negative for three consecutive months, it shall issue a major information notice to alert investors.
6. Countermeasures:
The company's operating revenue is recognized based on the valuation gains/losses (both realized and unrealized) of its investment targets. As the operating revenue has been negative for three consecutive months, a major information notice is being issued to alert investors.
7. Other matters to be noted (if the subject of the event or resolution is a publicly issued company or above, this major information also meets the criteria of Article 7, Paragraph 9 of the Enforcement Rules of the Securities Transaction Act regarding material impact on shareholder rights or securities prices):
The company's main investment targets are in the biotechnology sector, where stock prices and fair values are significantly affected by R&D outcomes, leading to substantial fluctuations. Therefore, a decline in fair value during the current year may result in negative operating revenue for the company.